Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report

  • Frank Leypoldt
  • Maarten J Titulaer
  • Esther Aguilar
  • Janine Walther
  • Marlene Bönstrup
  • Stefanie Havemeister
  • Bianca Teegen
  • Marc Lütgehetmann
  • Michael Rosenkranz
  • Tim Magnus
  • Josep Dalmau

Abstract

Relapsing symptoms post herpes simplex virus 1 (HSV) encephalitis (HSVE) usually occur a few weeks after viral therapy and represent either 1) a true viral relapse of HSVE (CSF PCR positive for HSV, new necrotic lesions on brain MRI, and response to acyclovir therapy) or 2) a disorder postulated to be immune-mediated (CSF negative for HSV, no new necrotic lesions, and no response to acyclovir).(1,2) It has been suggested that this immune-mediated disorder may be related to NMDA receptor (NMDAR) antibodies,(3) and we recently reported a child in whom relapsing symptoms post HSVE were the presentation of anti-NMDAR encephalitis.(4) We report an adult with this disorder, demonstrate that synthesis of NMDAR antibodies began after HSVE, and show that relapsing symptoms were due to steroid-responsive anti-NMDAR encephalitis.

Bibliografische Daten

OriginalspracheEnglisch
ISSN0028-3878
DOIs
StatusVeröffentlicht - 29.10.2013
PubMed 24089390